Table 3.
Predictivity of anti-C1q antibodies in SLE flares
| Number of patients (n) | Findings | Study |
|---|---|---|
| 68 | For renal flares: sensitivity 71%, specificity 92%, PPV 50%, NPV 97% | Siegert et al., 1993 [40] |
| 151 | 10 of 14 patients who developed proliferative nephritis had significant increases in anti-C1q level | Coremans et al., 1995 [15] |
| 151 | NPV 100% for nephritis | Marto et al., 2005 [39] |
| 70 | For severe lupus nephritis: sensitivity 100%, specificity 95.7%, PPV 50%, NPV 100% | Meyer et al., 2009 [30] |
| 23 | For renal flares: sensitivity 75.7%, specificity 84%, PPV 56%, NPV 70% | Matrat et al., 2011 [29] |
All anti-C1q antibodies were measured using enzyme-linked immunosorbent assays
NPV negative predictive value, PPV positive predictive value, SLE systemic lupus erythematosus